Amidines are potent inhibitors of nitric oxide synthases: preferential inhibition of the inducible isoform
- 30 November 1995
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 291 (3) , 311-318
- https://doi.org/10.1016/0922-4106(95)90071-3
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Characterisation of nitric oxide synthase activity in the rat colonic mucosa and muscle after endotoxin and in a model of colitisInflammation Research, 1994
- Inhibition of nitric oxide formation by guanidinesEuropean Journal of Pharmacology, 1993
- Inhibition of rat cerebellar nitric oxide synthase by 7‐nitro indazole and related substituted indazolesBritish Journal of Pharmacology, 1993
- Molecular mechanisms of nitric oxide regulation. Potential relevance to cardiovascular disease.Circulation Research, 1993
- Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunctionDiabetes, 1992
- Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophagesBiochemical and Biophysical Research Communications, 1991
- Importance of basal nitric oxide synthesis in regulation of myocardial blood flowCardiovascular Research, 1991
- Macrophage and endothelial cell nitric oxide synthesis: Cell-type selective inhibition by NG-aminoarginine, NG-nitroarginine and NG-methylarginineBiochemical and Biophysical Research Communications, 1990
- Control of regional blood flow by endothelium-derived nitric oxide.Hypertension, 1990
- Endothelial cells metabolize NG -monomethyl-L-arginine to L-citrulline and subsequently to L-arginineBiochemical and Biophysical Research Communications, 1990